OncoSec
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch OncoSec and buy or sell other stocks, ETFs, and their options commission-free!About ONCSQ
OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor.
CEORobert H. Arch, PhD
CEORobert H. Arch, PhD
Employees41
Employees41
HeadquartersEwing, New Jersey
HeadquartersEwing, New Jersey
Founded2008
Founded2008
Employees41
Employees41
ONCSQ Key Statistics
Market cap596.27
Market cap596.27
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume261.60
Average volume261.60
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0001
52 Week high$0.0001
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
With a market cap of 596.27, OncoSec(ONCSQ) trades at $0.00.
On 2026-10-26, OncoSec(ONCSQ) stock opened at —, reached a high of —, and a low of —.
OncoSec(ONCSQ) shares are trading with a volume of 0, against a daily average of 261.6.
In the last year, OncoSec(ONCSQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
In the last year, OncoSec(ONCSQ) shares hit a 52-week high of $0.00 and a 52-week low of $0.00.
People also own
Based on the portfolios of people who own ONCSQ. This list is generated using Robinhood data, and it’s not a recommendation.